COVID-19 Science & Society

Ravindra Gupta, MA, MPH, BMBCh, PhD, FRCP, FRCPath, FMedSci
University of Cambridge,
United Kingdom

Laura Waters, MD, FRCP
Central & North West London NHS Foundation Trust, 
United Kingdom

Monica Gandhi, MD, MPH
University of California San Francisco, 
United States

Jean Nachega MD, PhD, MPH, FRCP, FAAS
University of Pittsburgh / Johns Hopkins University, United States
Stellenbosch University, South Africa

Karine Lacombe, MD, PhD
Hôpital Saint Antoine Paris, France

Michel Kazatchkine, MD
The Global Health Center, Graduate Institute for International Affairs and Development

References:
The Independent Panel for Pandemic Preparedness & Response 

Kathryn Stephenson, MD, MPH
Beth Israel Deaconess Medical Center

Sanjay Bhagani, BSc, FRCP
Consultant Physician in Infectious Diseases/HIV Medicine and General (internal) Medicine, Royal Free Hospital

Daniel Kuritzkes, MD
Brigham and Women's Hospital; Harvard Medical School,
United States

Conflict of Interest Disclosure
Receipt of grants/research support from Atea, Gilead, Merck, and ViiV
Receipt of honoraria or consultation fees from Abpro, Atea, Decoy, Gilead, GlaxoSmithKline, Merck, Novartis, Rigel, ViiV

Long-term complications of COVID-19

Carlos del Rio, MD
Emory School of Medicine & Grady Health System,
United States

Conflict of interest disclosure
Carlos del Rio has received honoraria / consultation fees from Sanofi-Pasteur

References

US CDC - Post-COVID Conditions
https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html#:~:text=Post%2DCOVID%20conditions%20are%20a,can%20have%20post%2DCOVID%20conditions.

UK Office for National Statistics - Prevalence of Ongoing Symptoms Following COVID-19 infection in the UK
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/4june2021

COVID Symptom Study
https://covid.joinzoe.com/